Autoimmune CAR-T and Novel Therapies

CAR-T expanding into autoimmune diseases: miv-cel for stiff-person syndrome and myasthenia gravis (BLA Q4 2026), C-CAR168 for lupus nephritis, and first CAR-T for MS patient treated. New 3D genomics link CLN3 to Crohn's disease. EU approves nerandomilast for IPF/PPF. Psilocybin-assisted therapy shows 75% PTSD remission in veterans; VA launches new psilocybin trial.